Literature DB >> 24417420

Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients.

Deborah Tamura1, John J DiGiovanna, Sikandar G Khan, Kenneth H Kraemer.   

Abstract

Xeroderma pigmentosum (XP) is a rare autosomal recessive disease of deoxyribonucleic acid (DNA) repair with ultraviolet (UV) radiation sensitivity and a 10 000-fold increased risk of skin cancer. Symptoms include: freckle-like pigmentation in sun-exposed skin before age 2 years, severe burns after minimal sun exposure (50% of patients) and damage to exposed surfaces of the eyes with loss of vision and ocular cancer. About 25% of patients develop a progressive neurodegeneration. The combination of an inherited inability to repair UV-induced DNA damage and environmental exposure to UV must occur for cutaneous and ocular symptoms to develop. There is no cure for XP, but many of its manifestations may be reduced or prevented through consistent UV protection; thus XP serves as a model for sun protection of patients with marked photosenstivity. Sun protective clothing including hats, sunglasses and face shields, sun screen lotions and avoidance of environmental sources of UV are cornerstones of prevention of skin and eye damage and cancer. Although XP is a serious disease with the potential for limitation of life expectancy, XP patients can live active lives while at the same time avoiding UV. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  DNA repair; genetic disease; skin cancer; sun protection; xeroderma pigmentosum

Mesh:

Substances:

Year:  2014        PMID: 24417420      PMCID: PMC6334764          DOI: 10.1111/phpp.12108

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  24 in total

Review 1.  Ocular manifestations in the inherited DNA repair disorders.

Authors:  Hélène Dollfus; Fernanda Porto; Patrick Caussade; Claude Speeg-Schatz; José Sahel; Edouard Grosshans; Jacques Flament; Alain Sarasin
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

Review 2.  Xeroderma pigmentosum.

Authors:  Sandra Webb
Journal:  BMJ       Date:  2008-02-23

Review 3.  Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.

Authors:  K H Kraemer; N J Patronas; R Schiffmann; B P Brooks; D Tamura; J J DiGiovanna
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

4.  Xeroderma pigmentosum in Libya.

Authors:  M L Khatri; M Bemghazil; M Shafi; A Machina
Journal:  Int J Dermatol       Date:  1999-07       Impact factor: 2.736

5.  Neurological symptoms and natural course of xeroderma pigmentosum.

Authors:  Anu Anttinen; Leena Koulu; Eeva Nikoskelainen; Raija Portin; Timo Kurki; Matti Erkinjuntti; Nicolaas G J Jaspers; Anja Raams; Michael H L Green; Alan R Lehmann; Jonathan F Wing; Colin F Arlett; Reijo J Marttila
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

6.  Xeroderma pigmentosum-variant patients from America, Europe, and Asia.

Authors:  Hiroki Inui; Kyu-Seon Oh; Carine Nadem; Takahiro Ueda; Sikandar G Khan; Ahmet Metin; Engin Gozukara; Steffen Emmert; Hanoch Slor; David B Busch; Carl C Baker; John J DiGiovanna; Deborah Tamura; Cornelia S Seitz; Alexei Gratchev; Wen Hao Wu; Kee Yang Chung; Hye Jin Chung; Esther Azizi; Roger Woodgate; Thomas D Schneider; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

7.  Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2).

Authors:  Steffen Emmert; Takahiro Ueda; Urs Zumsteg; Peter Weber; Sikandar G Khan; Kyu-Seon Oh; Jennifer Boyle; Petra Laspe; Karolin Zachmann; Lars Boeckmann; Christiane Kuschal; Andreas Bircher; Kenneth H Kraemer
Journal:  Exp Dermatol       Date:  2008-07-07       Impact factor: 3.960

8.  Skin cancers, blindness, and anterior tongue mass in African brothers.

Authors:  Priya Mahindra; John J DiGiovanna; Deborah Tamura; Jaime S Brahim; Thomas J Hornyak; Jere B Stern; Chyi-Chia Richard Lee; Sikandar G Khan; Brian P Brooks; Janine A Smith; Brian P Driscoll; Andrew D Montemarano; Kate Sugarman; Kenneth H Kraemer
Journal:  J Am Acad Dermatol       Date:  2008-11       Impact factor: 11.527

Review 9.  The involvement of DNA-damage and -repair defects in neurological dysfunction.

Authors:  Avanti Kulkarni; David M Wilson
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

10.  Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.

Authors:  Wim J Kleijer; Vincent Laugel; Mark Berneburg; Tiziana Nardo; Heather Fawcett; Alexei Gratchev; Nicolaas G J Jaspers; Alain Sarasin; Miria Stefanini; Alan R Lehmann
Journal:  DNA Repair (Amst)       Date:  2008-03-10
View more
  18 in total

Review 1.  Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.

Authors:  Rosella Abeti; Anna Zeitlberger; Colm Peelo; Hiva Fassihi; Robert P E Sarkany; Alan R Lehmann; Paola Giunti
Journal:  Br J Pharmacol       Date:  2019-01-23       Impact factor: 8.739

2.  Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers.

Authors:  K H Kraemer; D Tamura; S G Khan
Journal:  Br J Dermatol       Date:  2018-05       Impact factor: 9.302

Review 3.  Comparison of mice with accelerated aging caused by distinct mechanisms.

Authors:  Aditi U Gurkar; Laura J Niedernhofer
Journal:  Exp Gerontol       Date:  2015-01-21       Impact factor: 4.032

Review 4.  Xeroderma Pigmentosum.

Authors:  Jennifer O Black
Journal:  Head Neck Pathol       Date:  2016-03-14

Review 5.  Xeroderma pigmentosum: an updated review.

Authors:  Alexander Kc Leung; Benjamin Barankin; Joseph M Lam; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2022-04-25

6.  XRCC1 and XPD polymorphisms and their relation to the clinical course in hepatocarcinoma patients.

Authors:  Qinghai Guan; Zhiqiang Chen; Qiangpu Chen; Xuting Zhi
Journal:  Oncol Lett       Date:  2017-07-05       Impact factor: 2.967

7.  Reproductive Health in Xeroderma Pigmentosum: Features of Premature Aging.

Authors:  Melissa Merideth; Deborah Tamura; Divya Angra; Sikandar G Khan; Joyln Ferrell; Alisa M Goldstein; John J DiGiovanna; Kenneth H Kraemer
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.623

8.  Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging.

Authors:  S D Kouatcheu; J Marko; D Tamura; S G Khan; C R Lee; J J DiGiovanna; K H Kraemer
Journal:  J Endocrinol Invest       Date:  2020-11-05       Impact factor: 5.467

9.  Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the 'XPAND' intervention.

Authors:  Kirby Sainsbury; Jessica Walburn; Lesley Foster; Myfanwy Morgan; Robert Sarkany; John Weinman; Vera Araujo-Soares
Journal:  Health Psychol Behav Med       Date:  2020-11-07

Review 10.  Genome Instability in Development and Aging: Insights from Nucleotide Excision Repair in Humans, Mice, and Worms.

Authors:  Diletta Edifizi; Björn Schumacher
Journal:  Biomolecules       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.